AmerisourceBergen Corp. (NYSE:ABC) has been assigned a consensus rating of “Buy” from the nineteen ratings firms that are covering the company, MarketBeat reports. One equities research analyst has rated the stock with a sell recommendation, six have given a hold recommendation, ten have given a buy recommendation and one has assigned a strong buy recommendation to the company. The average twelve-month price target among brokerages that have issued a report on the stock in the last year is $101.17.

Several research firms have recently weighed in on ABC. Jefferies Group set a $95.00 target price on shares of AmerisourceBergen and gave the company a “hold” rating in a report on Wednesday, February 7th. TheStreet raised shares of AmerisourceBergen from a “c” rating to a “b” rating in a research note on Tuesday, February 6th. Zacks Investment Research raised shares of AmerisourceBergen from a “hold” rating to a “buy” rating and set a $103.00 price target on the stock in a research note on Thursday, February 8th. Needham & Company LLC dropped their price target on shares of AmerisourceBergen from $117.00 to $113.00 and set a “buy” rating on the stock in a research note on Thursday, February 8th. Finally, Credit Suisse Group reissued an “outperform” rating and issued a $112.00 price target (up previously from $105.00) on shares of AmerisourceBergen in a research note on Wednesday, February 7th. They noted that the move was a valuation call.

In other AmerisourceBergen news, Director Richard W. Gochnauer sold 2,000 shares of AmerisourceBergen stock in a transaction on Wednesday, November 29th. The shares were sold at an average price of $85.00, for a total transaction of $170,000.00. Following the sale, the director now owns 12,947 shares of the company’s stock, valued at approximately $1,100,495. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Dale Danilewitz sold 4,459 shares of AmerisourceBergen stock in a transaction on Monday, November 20th. The stock was sold at an average price of $78.30, for a total transaction of $349,139.70. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 203,077 shares of company stock worth $18,288,730. 27.30% of the stock is currently owned by corporate insiders.

Institutional investors and hedge funds have recently made changes to their positions in the business. First Merchants Corp boosted its stake in AmerisourceBergen by 160.5% during the 3rd quarter. First Merchants Corp now owns 27,342 shares of the company’s stock worth $2,262,000 after purchasing an additional 16,848 shares during the last quarter. Tokio Marine Asset Management Co. Ltd. boosted its stake in AmerisourceBergen by 23.3% during the 3rd quarter. Tokio Marine Asset Management Co. Ltd. now owns 4,459 shares of the company’s stock worth $369,000 after purchasing an additional 842 shares during the last quarter. Wedge Capital Management L L P NC boosted its stake in AmerisourceBergen by 17.3% during the 3rd quarter. Wedge Capital Management L L P NC now owns 494,216 shares of the company’s stock worth $40,896,000 after purchasing an additional 72,743 shares during the last quarter. Achmea Investment Management B.V. boosted its stake in AmerisourceBergen by 7.8% during the 2nd quarter. Achmea Investment Management B.V. now owns 29,338 shares of the company’s stock worth $2,770,000 after purchasing an additional 2,123 shares during the last quarter. Finally, Burgundy Asset Management Ltd. boosted its stake in AmerisourceBergen by 3.3% during the 2nd quarter. Burgundy Asset Management Ltd. now owns 2,649,123 shares of the company’s stock worth $250,422,000 after purchasing an additional 84,163 shares during the last quarter. 66.84% of the stock is currently owned by institutional investors.

AmerisourceBergen (NYSE ABC) traded down $1.32 during trading hours on Wednesday, hitting $96.45. 3,242,865 shares of the stock traded hands, compared to its average volume of 2,177,976. The company has a debt-to-equity ratio of 1.61, a quick ratio of 0.50 and a current ratio of 0.95. The stock has a market cap of $21,480.00, a price-to-earnings ratio of 21.89, a price-to-earnings-growth ratio of 1.43 and a beta of 1.02. AmerisourceBergen has a 52-week low of $71.90 and a 52-week high of $106.27.

AmerisourceBergen (NYSE:ABC) last posted its earnings results on Tuesday, February 6th. The company reported $1.55 earnings per share for the quarter, beating the consensus estimate of $1.35 by $0.20. The firm had revenue of $40.47 billion during the quarter, compared to analyst estimates of $40.42 billion. AmerisourceBergen had a net margin of 0.66% and a return on equity of 53.65%. The business’s quarterly revenue was up 6.0% on a year-over-year basis. During the same period in the previous year, the firm earned $1.36 EPS. equities research analysts forecast that AmerisourceBergen will post 6.58 EPS for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Monday, March 5th. Shareholders of record on Tuesday, February 20th will be paid a dividend of $0.38 per share. The ex-dividend date of this dividend is Friday, February 16th. This represents a $1.52 annualized dividend and a yield of 1.58%. AmerisourceBergen’s dividend payout ratio (DPR) is presently 34.47%.

COPYRIGHT VIOLATION WARNING: This story was reported by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are accessing this story on another site, it was stolen and reposted in violation of US & international copyright legislation. The original version of this story can be read at https://theolympiareport.com/2018/02/14/amerisourcebergen-corp-abc-given-consensus-rating-of-buy-by-brokerages.html.

AmerisourceBergen Company Profile

AmerisourceBergen Corporation is a pharmaceutical sourcing and distribution services company. The Company’s segments include Pharmaceutical Distribution and Other. The Company provides services to healthcare providers, and pharmaceutical and biotech manufacturers. As of June 30, 2016, the Pharmaceutical Distribution segment consists of two operating segments, including the operations of AmerisourceBergen Drug Corporation (ABDC) and AmerisourceBergen Specialty Group (ABSG), which distributes specialty drugs to their customers.

Analyst Recommendations for AmerisourceBergen (NYSE:ABC)

Receive News & Ratings for AmerisourceBergen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AmerisourceBergen and related companies with MarketBeat.com's FREE daily email newsletter.